Meeker David P
Director | President And CEO | Director, 10% Owner
3 companies
Insider Signal Score
31
WeakTrades Analyzed
7
12M Win Rate
0.0%
Avg 3M Return
-10.0%
Avg 12M Return
-57.9%
Meeker David P is a Director at Trevi Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 7 sells.
Estimated insider holdings value: $36.9M based on current market prices.
Holdings by Company
Transaction History
Showing 9 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | President And CEO | Sale+OE | 43,620 | $65.05 | $2,837,333.35 | -9.7% | +58.7% | +33.8% | |
| Feb 19, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | President And CEO | Sale+OE | 9,896 | $57.22 | $566,249.12 | -4.7% | +10.1% | +77.9% | |
| Feb 4, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | President And CEO | Sale+OE | 4,278 | $59.43 | $254,241.54 | -2.2% | +7.4% | +80.1% | |
| Aug 27, 2024 | TRVI Trevi Therapeutics, Inc. | Director | Sale+OE | 4,555 | $2.93 | $13,352.53 | -1.3% | +0.3% | +174.9% | |
| Mar 19, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | President And CEO | Sell | 45,494 | $39.22 | $1,784,274.68 | -20.7% | +5.2% | +41.1% | |
| Feb 1, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | President And CEO | Sale+OE | 4,361 | $45.06 | $196,506.66 | -3.5% | -10.6% | +28.3% | |
| Mar 30, 2021 | RYTM Rhythm Pharmaceuticals, Inc. | President And CEO | Buy | 10,000 | $20.17 | $201,713.00 | +9.9% | +1.5% | -44.2% | |
| May 9, 2019 | TRVI Trevi Therapeutics, Inc. | Director, 10% Owner | Buy | 11,250 | $10.00 | $112,500.00 | +3.3% | - | - | |
| Oct 10, 2017 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Buy | 25,000 | $17.00 | $425,000.00 | +32.8% | - | - |